Avidity Biosciences - 53 Year Dividend History | RNA
Historical dividend payout and yield for Avidity Biosciences (RNA) since 1971. The current TTM dividend payout for Avidity Biosciences (RNA) as of December 20, 2024 is $0.00. The current dividend yield for Avidity Biosciences as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$3.876B |
$0.010B |
|
Avidity Biosciences Inc. is a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates(TM). The company's AOC platform design, engineer and develop therapeutics which combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies. Its lead product candidate consist AOC 1001, is designed to treat myotonic dystrophy type 1,and other muscle programs are focused on the treatment of muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy and Pompe disease. Avidity Biosciences Inc. is based in SAN DIEGO.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
